San Antonio, TX, United States of America

Beth A Goins



Average Co-Inventor Count = 2.9

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2006-2014

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Beth A. Goins

Introduction

Beth A. Goins is a prominent inventor based in San Antonio, Texas. She has made significant contributions to the field of drug delivery systems, particularly in the context of bone and joint health. With a total of three patents to her name, her work has the potential to impact medical treatments and improve patient outcomes.

Latest Patents

One of her latest patents is focused on bone marrow-directing drug delivery materials and their applications. This invention pertains to a drug delivery material that includes fine particles with an anionic moiety on their surface. The material is designed for the prevention, treatment, or diagnosis of diseases affecting bone, cartilage, bone marrow, or joints. Additionally, she has developed methods for administering this material to subjects in need of treatment.

Another notable patent involves radiolabeled compounds and liposomes, along with methods for their production and use. This invention also includes kits for preparing radiolabeled liposomes, which can be crucial for various medical applications.

Career Highlights

Beth A. Goins has worked with esteemed institutions such as the University of Texas System and Waseda University. Her experience in these organizations has allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.

Collaborations

Throughout her career, she has collaborated with notable colleagues, including William T. Phillips and Ande Bao. These partnerships have further enhanced her research and innovation efforts.

Conclusion

Beth A. Goins exemplifies the spirit of innovation in the medical field through her patents and research. Her work in drug delivery systems holds promise for advancing treatments for bone and joint diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…